13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Pacific-R

    Acronym: 

    Pacific-R

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Lung & mesothelioma
    Trial Type Treatment
    Phase All phases Tumour Stream Non-small cell lung cancer (NSCLC)
    Age Range 18 years and older Cancer Stage
    Sex Both Anticipated Start Date 2019-04-01
    Molecular Target Anticipated End Date
    Cancer Type Lung & mesothelioma
    Trial Type Treatment
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Non-small cell lung cancer (NSCLC)
    Cancer Stage
    Anticipated Start Date 2019-04-01
    Anticipated End Date

    Trial Summary

    First real-world data on unresectable stage III NSCLC patients with durvalumab after chemoradiotherapy (Retrospective data collection from patients with durvalumab via EAP)

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Calvary Central Districts Hospital Julie Rowe julie.rowe@calvarycare.org.au 08 8239 9536 Recruiting